Module 1: GIST primary and recurrent
Available from September 2026
Module 1: GIST primary and recurrent
Available from September 2026
01/09/2026
Biology of GIST
01/09/2026
Pathological and molecular diagnosis
01/09/2026
Surgery of GIST
01/09/2026
Management of primary localized disease
01/09/2026
Management of metastatic disease
01/09/2026
New drugs and clinical trials
01/09/2026
Rare GIST subtypes
01/09/2026
Monitoring advanced GIST with circulating tumor DNA
01/09/2026
Current controversies
01/09/2026
Understanding KIT inhibitors resistance
01/09/2026
Clinical case discussion (live online session)
Module director: Mehdi Brahmi, FR
Andrea Napolitano
NHS practice at The Royal Marsden, Medical Oncology Dpt., London, UK
Dimitri Tzanis
Institute Curie, Sarcoma Dpt., Paris, FR
George Demetri
Dana-Farber Cancer Institute, Sarcoma Dpt., Boston, US
Jean-yves Blay
University Claude Bernard Lyon I, Centre Léon Bérard, Dept. of Medicine, Lyon, FR
Nadia Hindi
Hospital Fundación Jimenez Díaz, Medical Oncology, Madrid, ES
Peter Reichardt
Helios Clinic Berlin-Buch, Sarcoma Dpt., Berlin, DE
